• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    3M Reports Fourth-Quarter and Full-Year 2024 Results; Initiates Full-Year 2025 Financial Guidance

    1/21/25 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    • Q4 sales of $6.0 billion, up 0.1% YoY; adjusted sales of $5.8 billion with organic growth up 2.1% YoY
    • Q4 GAAP EPS from continuing operations of $1.33, up 17% YoY; adjusted EPS from continuing operations of $1.68, down 2% YoY
    • Full-year sales of $24.6 billion, down 0.1% YoY; adjusted sales of $23.6 billion with organic growth of 1.2% YoY
    • Full-year GAAP EPS from continuing operations of $7.26; adjusted EPS from continuing operations of $7.30, up 21% YoY
    • Full-year operating cash flow of $1.8 billion with adjusted free cash flow of $4.9 billion

    ST. PAUL, Minn., Jan. 21, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported fourth-quarter and full-year 2024 results and provided its 2025 financial guidance.

    "Our fourth quarter capped a year of strong results as we returned to positive organic revenue growth in the full year," said William Brown, 3M Chief Executive Officer. "I would like to thank the 3M team for their strong operational execution which helped us deliver double-digit earnings growth and robust free cash flow while returning $3.8 billion to shareholders. We are carrying this momentum forward and are confident in our ability to deliver our 2025 guidance."

    Fourth-Quarter Highlights:











    Q4 2024



    Q4 2023









    GAAP EPS from continuing operations (GAAP EPS)



    $          1.33



    $          1.14









    Special items:

















    Net costs for significant litigation



    (0.07)



    0.36









    (Increase) decrease in value of Solventum ownership



    0.24



    —









    Other special items, net



    0.18



    0.20









    Adjusted EPS from continuing operations (Adjusted EPS)



    $          1.68



    $          1.70



























    Memo:

















    GAAP operating income margin



    18.1 %



    15.0 %









    Adjusted operating income margin



    19.7 %



    19.9 %



    • GAAP EPS of $1.33 and operating margin of 18.1%.
    • Adjusted EPS of $1.68, down 2% year-on-year.
    • Adjusted operating income margin of 19.7%, a decrease of 0.2 percentage points year-on-year.










    GAAP



    Adjusted (Non-GAAP)









    Net sales (Millions)



    $6,010



    $5,808









    Sales change

















    Total sales



    0.1 %



    2.2 %









    Components of sales change:

















    Organic sales1



    — %



    2.1 %









    Acquisitions/divestitures



    0.9 %



    0.9 %









    Translation



    (0.8) %



    (0.8) %









    Adjusted sales excludes manufactured PFAS products.









    1Above adjusted organic sales increase includes a 70 basis point headwind from product portfolio initiatives and exit of

    certain small countries.



    • Sales of $6.0 billion, up 0.1% year-on-year with organic sales flat year-on-year.
    • Adjusted sales of $5.8 billion, up 2.2% year-on-year with adjusted organic sales up 2.1% year-on-year.
    • 3M returned $1.1 billion to shareholders via dividends and share repurchases.
    • Cash from operations of $1.8 billion.
    • Adjusted free cash flow of $1.3 billion.

    Full-Year Highlights:











    Full Year 2024



    Full Year 2023









    GAAP earnings (loss) per share from continuing operations



    $          7.26



    $        (15.17)









    Special items:

















    (Increase) decrease in value of Solventum ownership



    (2.83)



    —









    Net costs for significant litigation



    1.32



    21.00









    Pension risk transfer charge



    1.11



    —









    Other special items, net



    0.44



    0.21









    Adjusted earnings per share (EPS) from continuing operations



    $          7.30



    $          6.04



























    Memo:

















    GAAP operating income (loss) margin



    19.6 %



    (43.4) %









    Adjusted operating income margin



    21.4 %



    18.6 %



    • GAAP EPS of $7.26 and operating margin of 19.6%.
    • Adjusted EPS of $7.30, up 21% year-on-year.










    GAAP



    Adjusted (Non-GAAP)









    Net sales (Millions)



    $24,575



    $23,630









    Sales change

















    Total sales



    (0.1) %



    1.3 %









    Components of sales change:

















    Organic sales2



    (0.2) %



    1.2 %









    Acquisitions/divestitures



    0.8 %



    0.9 %









    Translation



    (0.7) %



    (0.8) %









    Adjusted sales excludes manufactured PFAS products.









    2Above adjusted organic sales increase includes a 110 basis point headwind from product portfolio initiatives

    and exit of certain small countries.



    • Sales of $24.6 billion, down 0.1 percent year-on-year with organic sales decline of 0.2 percent year-on-year.
    • Adjusted sales of $23.6 billion, up 1.3 percent year-on-year with adjusted organic sales increase of 1.2 percent year-on-year.
    • 3M returned $3.8 billion to shareholders via dividends and share repurchases.
    • Cash from operations of $1.8 billion, including $3.8 billion net after tax payments for costs of significant litigation, primarily Public Water Systems and Combat Arms Earplugs.
    • Adjusted free cash flow of $4.9 billion.

    This document includes reference to certain non-GAAP measures. See the "Supplemental Financial Information Non-GAAP Measures" section for applicable information.

    Full-Year 2025 Guidance

    3M provided the following full-year 2025 expectations.

    • Adjusted total sales growth3 in the range of 0.5 to 1.5 percent, reflecting adjusted organic sales3 growth of 2 to 3 percent.
    • Adjusted EPS3 in the range of $7.60 to $7.90.
    • Adjusted operating cash flow3 of $5.2 to $5.3 billion, contributing to approximately 100 percent adjusted free cash flow conversion3.

    3As further discussed at 6 within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.

    Conference Call

    3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:

    • Live webcast at https://investors.3M.com 
    • Webcast replay at https://investors.3m.com/financials/quarterly-earnings 

    Consolidated Financial Statements and Supplemental Financial Information Non-GAAP Measures

    View the Financial Statement Information on 3M's website: https://investors.3m.com/financials/quarterly-earnings

    Forward-Looking Statements

    This news release contains forward-looking statements. You can identify these statements by the use of words such as "plan," "expect," "aim," "believe," "project," "target," "anticipate," "intend," "estimate," "will," "should," "could," "would," "forecast" and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation, recession, military conflicts, and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals; known as "PFAS," including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's plans to exit PFAS manufacturing and work to discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement to resolve claims by public water suppliers in the United States regarding PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q and 8-K (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning system, or security breaches and other disruptions to the Company's information or operational technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company's Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; the risk that any consents or approvals required will not be obtained; risks under the agreements and obligations entered into in connection with the spin-off, and (16) matters relating to Combat Arms Earplugs ("CAE"), including those related to, the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company's subsidiary Aearo Technologies and certain of its affiliates and/or the Company. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

    About 3M

    3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news.

    Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M News Center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the News Center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M's news center and the social media channels such as @3M or @3MNews.

    Contacts

    3M

    Investor Contacts:

    Diane Farrow, 612-202-2449

    or

    Eric Herron, 651-233-0043

    Media Contact:

    Sean Lynch, [email protected]

    3M (PRNewsfoto/3M)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/3m-reports-fourth-quarter-and-full-year-2024-results-initiates-full-year-2025-financial-guidance-302355783.html

    SOURCE 3M Company

    Get the next $MMM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    7/29/2024$110.00 → $150.00Hold → Buy
    Deutsche Bank
    6/13/2024$125.00Peer Perform → Outperform
    Wolfe Research
    6/7/2024$105.00 → $120.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

      For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

      1/22/21 3:54:10 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Group President Pilz Torsten

      4 - 3M CO (0000066740) (Issuer)

      6/3/25 2:57:05 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Executive Vice President Banovetz John Patrick exercised 7,759 shares at a strike of $130.14 and sold $1,151,237 worth of shares (7,759 units at $148.37), decreasing direct ownership by 0.00% to 31,372 units (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/27/25 8:20:05 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • EVP, Chief Legal Off & Secret Rhodes Kevin H exercised 7,976 shares at a strike of $130.14 and sold $1,228,464 worth of shares (7,976 units at $154.02) (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/21/25 4:04:30 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • 3M upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded 3M from Equal Weight to Overweight and set a new price target of $170.00 from $140.00 previously

      1/22/25 7:45:34 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by UBS with a new price target

      UBS upgraded 3M from Neutral to Buy and set a new price target of $184.00

      11/13/24 8:05:47 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by Melius

      Melius upgraded 3M from Hold to Buy

      10/22/24 11:24:35 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • A3 and 3M Bring Premier Robotic Grinding & Finishing Conference to Minneapolis, July 22-23

      Agenda now available for next-gen robotic material removal and finishing event The Association for Advancing Automation (A3) today announced the full agenda for its Robotic Grinding and Finishing Conference, set for July 22-23 at the Hyatt Regency Minneapolis. Co-presented with 3M, the two-day event will unite manufacturers, integrators, and automation experts for deep-dive technical sessions, live robotic demos, and peer networking focused on next-generation material-removal solutions that boost quality, throughput, and worker safety. Registration is open at https://www.automate.org/events/robotic-grinding-and-finishing-conference. "Robotic grinding and finishing applications are rapid

      6/4/25 11:56:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Scotch Painter's Tape introduces ScotchBlue PROSharp Painter's Tape with Edge-Lock+ Technology

      ScotchBlue PROSharp Painter's Tape provides ultra-sharp paint lines, helping to achieve a professional grade finish ST. PAUL, Minn., May 21, 2025 /PRNewswire/ -- ScotchBlue™ PROSharp™ Painter's Tape with Edge-Lock+™ Technology is redefining precision lines within its portfolio of painter tapes. Backed by 100 years of innovation, the new advanced Edge-Lock+ Technology delivers a 2x better hold*, sealing out paint to leave consistently sharp lines, reducing the need for touch-ups and repaints. "Professional painters know the best paint jobs start with Scotch," said Heather Green

      5/21/25 11:36:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Annual Meeting Results

      ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company. Preliminary Shareholder Voting Results 3M shareholders today voted on the following business items: 1) Shareholders supported 11 directors for one-year terms to expire at the company's 2026 Annual Meeting: David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford

      5/13/25 4:30:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Financials

    Live finance-specific insights

    See more
    • 3M Board Declares Quarterly Dividend

      ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- The 3M Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.73 per share for the second quarter of 2025. The dividend is payable June 12, 2025, to shareholders of record at the close of business on May 23, 2025. 3M has paid dividends to its shareholders without interruption for more than 100 years. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve live

      5/13/25 4:15:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Reports First-Quarter 2025 Results

      GAAP sales of $6.0 billion, down 1.0% YoY; operating margin 20.9%, up 180 bps YoY; EPS of $2.04, up 61% YoYAdjusted sales of $5.8 billion with organic growth of 1.5% YoYAdjusted operating margin of 23.5%, up 220 bps YoYAdjusted EPS of $1.88, up 10% YoYOperating cash flow of $(0.1) billion with adjusted free cash flow of $0.5 billionUpdated 2025 guidance and providing tariff sensitivityST. PAUL, Minn., April 22, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter 2025 results. "We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and Chief Executive Officer. "In th

      4/22/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Announces Upcoming Investor Event

      ST. PAUL, Minn., Apr. 8, 2025 /PRNewswire/ -- 3M (NYSE: MMM) today announced the following investor event: First-quarter 2025 earnings conference call on Tuesday, Apr. 22, 2025, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news. Investor Contact:Diane Farrow

      4/8/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    SEC Filings

    See more
    • SEC Form SD filed by 3M Company

      SD - 3M CO (0000066740) (Filer)

      5/30/25 8:15:17 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - 3M CO (0000066740) (Filer)

      5/14/25 5:18:32 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Company filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - 3M CO (0000066740) (Filer)

      5/12/25 4:16:24 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/13/24 4:56:03 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/23 10:54:46 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/22 3:15:56 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    See more
    • 3M Annual Meeting Results

      ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company. Preliminary Shareholder Voting Results 3M shareholders today voted on the following business items: 1) Shareholders supported 11 directors for one-year terms to expire at the company's 2026 Annual Meeting: David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford

      5/13/25 4:30:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Announces New Board Appointments

      William Brown to become Chairman of the Board of DirectorsMike Roman to retire as Executive Chairman and Director and become Executive Advisor to the BoardDavid Bozeman elected to the BoardAmy Hood does not intend to stand for reelectionST. PAUL, Minn., Feb. 10, 2025 /PRNewswire/ -- 3M (NYSE:MMM) announced today changes to its Board of Directors and Board leadership structure. William M. "Bill" Brown, 3M's Chief Executive Officer and Director, has been appointed by the Board to serve as its Chairman, effective March 1, 2025 in addition to his current responsibilities.  Michael F. Roman, Executive Chairman of the Board of Directors, has announced his intention to retire as Executive Chairman,

      2/10/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M joins consortium to accelerate semiconductor technology in the US

      ST. PAUL, Minn., Feb. 3, 2025  /PRNewswire/ -- 3M is expanding its commitment to the semiconductor industry by joining the US-JOINT Consortium, a strategic partnership of 12 leading semiconductor suppliers. The consortium drives research and development in next-generation semiconductor advanced packaging and back-end processing technologies anchored by a new cutting-edge facility in Silicon Valley. "As the demands of AI and other high performance computing technologies increase, suppliers must work together to provide comprehensive solutions to tough challenges on increasingly

      2/3/25 10:55:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care